Physicians in virtually all specialties assess and treat patients who are in discomfort. Pain medication and pain control remain a focus for many educational programs that aim to reduce the ongoing epidemic of opioid misuse. We believe The Doctors Company can contribute additional insights to help physicians better recognize potential issues and manage the medications used to treat pain. By sharing what we have gleaned from analyzing professional liability claims and other data, we hope to reduce potential medical malpractice liability exposures that may arise from pain management practices. Perspectives on Opioids and Pain Management incorporates articles by Dr. Roneet, Lev Dr. David Troxel, and Dr. Howard Marcus that were published in the 1st and 2nd Quarters 2017 of The Doctor’s Advocate.
After completing this activity, learners will be able to:
- Recognize the impact of opioid prescribing and usage on communities.
- Identify allegations and contributing factors in malpractice suits related to controlled medications.
- Take steps to assist patients to manage pain and to minimize addiction to controlled medications.
No individual in a position to control or influence the content of this activity has reported relevant financial relationships with commercial interests. No commercial support was provided for this activity.
Julie Hopkins, MA, MBA Director, Continuing Medical Education, Patient Safety and Risk Management Department
Susan Shepard, MSN MA RN CPHRM, Senior Director, Patient Safety and Risk Management Education
Continuing Education Credit
The Doctors Company is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
The Doctors Company designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Doctors Company estimates one hour for completion of this course. A passing score of 80 percent or greater is required to successfully complete the activity and earn AMA PRA Category 1 Credit™.
|Course ID#:||TDE 17018.0|
|Issue Date for This Activity:||06/09/2017|
|Expiration Date for This Activity:||06/09/2020|
The information and guidelines contained in this enduring material activity are generalized and may not apply to all practice situations. The Doctors Company recommends that legal advice be obtained from a qualified attorney for specific application to your practice. The information in this activity is intended for educational purposed only.
Complies with State Requirements
Please click HERE to see the Federation of State Medical Boards overview of Continuing Medical Education by State.
Currently, Prespectives on Opioids and Pain Management is not recognized by any Licensing Board in the state of Florida as meeting the continuing education requirements defined by HB21, Controlled Substance Prescribing, that became effective July 1, 2018.
Click Here to download a PDF with resources related to this program
If you have questions, contact email@example.com or call (800) 421-2368, extension 1243.